Aurinia Pharmaceuticals Inc (AUPH) — Cash Flow Quality Index
Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow Quality Index of 0.95x as of March 2026. Operating cash flow of $32.56 Million is below net income of $34.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Aurinia Pharmaceuticals Inc generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aurinia Pharmaceuticals Inc Cash Flow Quality Index (2024–2025)
Historical Cash Flow Quality Index for Aurinia Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AUPH cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Aurinia Pharmaceuticals Inc (2024–2025)
Year-by-year earnings quality comparison for Aurinia Pharmaceuticals Inc. For live market cap and the full company financial profile, see Aurinia Pharmaceuticals Inc (AUPH) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | $135.66 Million | $287.20 Million | ▼ -93.9% |
| 2024 | 7.72x | $44.39 Million | $5.75 Million | — |